Results 121 to 130 of about 19,579 (254)

Pharmacoepidemiology and the Law

, 2012
Aaron S. Kesselheim
openalex   +1 more source

Real-world treatment patterns of rheumatoid arthritis in Brazil: analysis of DATASUS national administrative claims data for pharmacoepidemiology studies (2010–2020) [PDF]

, 2023
Marina Gabriela Birck, Rafaela Vansan Ferreira, Mariana Cúri, Whitney S. Krueger, Guilherme Silva Julian, Alexander Liede   +5 more
openalex   +1 more source

Prenatal Exposure to Modafinil and the Risk of Major Congenital Anomalies and Other Adverse Neonatal and Pediatric Outcomes

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 8, August 2026.
ABSTRACT Objective To assess the risk of major congenital anomalies (MCAs) and other adverse outcomes following prenatal exposure to modafinil. Methods This retrospective cohort study used the French national healthcare database (SNDS) to include singleton children born between January 2009 and September 2024 of women aged 15–55 years.
Melinda Kanoun, Naïm Bouazza, Jean‐Marc Treluyer, Mathis Collier   +3 more
wiley   +1 more source

Patterns of menopausal hormone therapy dispensing over 15 years—A Swedish register‐based cohort study

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 8, Page 1454-1467, August 2026.
In this Swedish register‐based cohort study, systemic menopausal hormone therapy dispensing decreased over 15 years, while local therapy increased. Age, cohort effects, and sociodemographic characteristics were associated with differences in dispensing patterns.
Rebecca Götze Eriksson, Fanny Söderquist, Ge Bai, Per Wikman, Diego Hernan Giunta, Inger Sundström Poromaa, Evangelia Elenis, Angelica Lindén Hirschberg, Alkistis Skalkidou, Stavros I. Iliadis   +9 more
wiley   +1 more source

Risk Assessment of New Drugs, Pharmacoepidemiology, and Regulatory Decisionmaking

, 2018
Robert C. Nelson
openalex   +1 more source

X National Congress with international participation «Development of pharmacoeconomics and pharmacoepidemiology in the Russian Federation», 4-5 april 2016 Nizhny Novgorod [PDF]

, 2016
D.T. Ugrekhelidze, V.G. Serpik
openalex   +1 more source

Identification, reliability, and validity of drug–drug interaction checkers in chronic diseases: A systematic review

British Journal of Pharmacology, Volume 183, Issue 16, Page 4532-4561, August 2026.
Abstract Drug–drug interactions (DDIs) pose major risks in chronic disease management where polypharmacy is common. Although digital DDI tools are used widely to aid healthcare professionals, tools rely on theoretical interactions. This limitation questions their reliability and validity for clinical relevancy.
Brayden Ng Gibson, Sri Chodapuneedi, Huan Yee Koh, Sugandha Gupta, Danijela Gasevic, Anna Yuanyuan Wang, Catia Marzolini, Saye Khoo, Lorena Romero, Lachlan Dalli, Jack Janetzki, Harvey Jia Wei Koh, Stella Talic   +12 more
wiley   +1 more source

Exploring Risks of Adverse Drug Events From Single Drug to Three‐Drug Combination

Clinical and Translational Science, Volume 19, Issue 8, August 2026.
ABSTRACT Use of three‐drug combinations is common and could increase the risk of adverse drug events (ADEs). Signals of ADEs from three‐drug combinations could be identified from real‐world data, and the risks of ADEs from single drug exposure to three‐drug combination exposure could be illustrated by a graphic model.
Yi Shi, Anna Sun, Chien‐Wei Chiang, Yuedi Yang, Katherine M. Hunold, Jing Xu, Mu Shan, Allison Lu, Massimiliano Russo, Jeffrey M. Caterino, Michael T. Eadon, Lang Li, Jing Su, Macarius Donneyong, Pengyue Zhang   +14 more
wiley   +1 more source

A Serverless Pharmacogenomic Risk Dashboard: Translating Ensemble Models and Model‐Based Scenario Rules to Clinical Decision Support

Clinical and Translational Science, Volume 19, Issue 8, August 2026.
ABSTRACT The “last mile” problem in healthcare AI—translating high‐performance models into accessible, privacy‐preserving point‐of‐care tools—remains unsolved for pharmacogenomic (PGx) risk assessment. No existing platform integrates opioid and polypharmacy risk scoring, model‐based scenario analysis, and CPIC‐based PGx patient cards within a single ...
R. Jerome Dixon, Elvin T. Price
wiley   +1 more source

Curriculum in Pharmacoepidemiology Training Programs: A Cross-Sectional Study to Assess Educational Needs and Alignment With Core Competencies. [PDF]

Pharmacoepidemiol Drug Saf
Goodin A, Layton D, Chung R, Osborne V, Ejekam C, Li X, Wen X, Filion KB, Lopes LC, Moga DC.   +9 more
europepmc   +1 more source